ACH
ACCENDRA HEALTH INC/VA/
NYSE · Healthcare · Medical - Distribution · US
$0.22
−6.30%Year over year
Reported trailing growth
- Revenue
- -60.5%
- EBITDA
- +463.8%
- EBIT
- +155.0%
- EPS
- +75.0%
- Free cash flow
- -28.0%
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- -4.1%
- EBITDA
- +55.3%
- EPS
- +99.1%
Three-year CAGR
- Revenue
- -34.8%
- EBITDA
- -15.8%
- EBIT
- +15.8%
- Net income
- —
- EPS
- —
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026